Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001610717-24-000496
Filing Date
2024-09-27
Accepted
2024-09-27 16:21:42
Documents
2
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1508
2 POWER OF ATTORNEY poa.htm EX-24.1 7453
  Complete submission text file 0001610717-24-000496.txt   10478
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB249BZ
Business Address
Snyder Douglas B. (Reporting) CIK: 0001754125 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38915 | Film No.: 241335174